Skip to content Skip to footer
Subscribe Now
Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
VIEWPOINTS

Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science

Shots:Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes)He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detailThe interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes careSmriti: Tell us how Lilly is leading…
August 16, 2022

Read more

PharmaShots Interview Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results
VIEWPOINTS

PharmaShots Interview: Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results

Shots:Dr. Mason spoke about the key findings from their in vitro study demonstrating EPA + statins effects in reduced lipid oxidation, which were presented at the ACC 2022He also spoke about the study design of the REDUCE-IT trial and its importance in the approval of its candidate in metabolic and cardiovascular diseasesThe interview summarizes…
August 3, 2022

Read more